<div class="pdf-content">
<p class="mb-3">FRCPath Part 2—Revision Notes on Aspergillus spp.</p>
<p class="mb-3">(Oxford Textbook of Medical Mycology, Ch 10)</p>
<h3 class="text-lg font-semibold mt-6 mb-3">1. Genus at a glance</h3>
<p class="ml-4 mb-2">• &gt; 200 species; &gt; 30 human pathogens—among the most ubiquitous environmental moulds;</p>
<p class="mb-3">conidia inhaled daily.</p>
<p class="ml-4 mb-2">• Characteristic aspergillum (asexual conidial head); despite known teleomorphs, the 2012</p>
<p class="mb-3">“one-fungus-one-name” rule retains Aspergillus nomenclature .</p>
<p class="ml-4 mb-2">• Commercial uses: A. niger → citric-acid &amp; enzyme production; A. oryzae → sake/soy</p>
<p class="mb-3">fermentation .</p>
<br/>
<h3 class="text-lg font-semibold mt-6 mb-3">2. Key species, temperatures, toxins &amp; clinical points</h3>
<p class="mb-3">Species</p>
<p class="mb-3">(complex) Opt. Temp / Range (°C) Colony / Microscopy Major toxin Salient clinical facts</p>
<p class="mb-3">A. fumigatus 37 / 12-65 Green-blue; columnar uniseriate heads — Commonest invasive isolate; ABPA, CPA</p>
<p class="mb-3">A. flavus 37 / 12-48 Green-yellow; radiate uni/bi-seriate Aflatoxin Sinusitis, keratitis, aflatoxicosis risk</p>
<p class="mb-3">A. niger 37 Black biseriate heads — Otomycosis, onychomycosis</p>
<p class="mb-3">A. terreus 25-40 Beige; biseriate + accessory conidia Ochratoxin Intrinsic AmB-R</p>
<p class="mb-3">A. nidulans 37 / 2-48 Green with red-brown cleistothecia — CGD infections; AmB-R</p>
<p class="mb-3">A. versicolor 22-26 (opt); ≤40 White→yellow/green; penicillium-like Sterigmatocystin Onychomycosis; grows best at room-temp</p>
<p class="mb-3">A. clavatus 37 Long club-shaped vesicle — Extrinsic allergic alveolitis (“malt-worker’s lung”)</p>
<br/>
<p class="mb-3">Memory hook: A. fumigatus thermotolerant to 65 °C; A. versicolor prefers ~25 °C—good MCQ bait .</p>
<br/>
<br/>
<br/>
<p class="mb-3">Green-yellow radiate, compare to A. fumigatus</p>
<br/>
<p class="mb-3">Cinnamon colored, columnar</p>
<br/>
<h3 class="text-lg font-semibold mt-6 mb-3">3. Epidemiology &amp; reservoirs</h3>
<p class="ml-4 mb-2">• Conidia in soil, rotting vegetation, damp building materials (wallpaper, concrete, pipe-</p>
<p class="mb-3">lagging, carpets, HVAC); hospital construction dust → outbreaks .</p>
<p class="ml-4 mb-2">• High-risk hosts: prolonged neutropenia, allogeneic-HSCT (~12 %), heart-lung Tx (11 %), CGD,</p>
<p class="mb-3">high-dose steroids .</p>
<p class="ml-4 mb-2">• CPA rising after TB, COPD, sarcoidosis .</p>
<h3 class="text-lg font-semibold mt-6 mb-3">4. Pathogenesis (4-step mnemonic I-G-A-T)</h3>
<p class="mb-3">1 Inhalation &amp; alveolar deposition</p>
<p class="mb-3">2 Germination when innate immunity fails</p>
<p class="mb-3">3 Angio-invasion → thrombosis, infarction</p>
<p class="mb-3">4 Toxins &amp; hypersensitivity drive allergic / chronic disease</p>
<h3 class="text-lg font-semibold mt-6 mb-3">5. Clinical spectrum</h3>
<p class="mb-3">Category Typical entities / notes</p>
<p class="mb-3">Non-invasive Otomycosis (A. niger), onychomycosis (A. versicolor),</p>
<p class="mb-3">allergic fungal rhinosinusitis</p>
<p class="mb-3">Allergic ABPA (≈16 % asthmatics); EAA by A. clavatus; SAFS</p>
<p class="mb-3">Chronic CPA continuum: simple aspergilloma → chronic cavitary →</p>
<p class="mb-3">fibrosing disease</p>
<p class="mb-3">Invasive Acute pulmonary IA ± CNS, eye, skin; sinusitis; mortality</p>
<h3 class="text-lg font-semibold mt-6 mb-3">50–85 %</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">6. Diagnosis workflow</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">1. Direct / culture: septate 45° branching hyphae; Sabouraud agar 48-90 h.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">2. Serology &amp; biomarkers:</h3>
<p class="mb-3">a. Aspergillus precipitins (IgG)—best single test for CPA/ABPA support .</p>
<p class="mb-3">b. Galactomannan ELISA / LFD (false-pos with β-lactams) .</p>
<p class="mb-3">c. (1→3) β-D-glucan (pan-fungal) .</p>
<p class="mb-3">d. PCR on blood/BAL; combine with GM for ↑ sensitivity .</p>
<h3 class="text-lg font-semibold mt-6 mb-3">3. Imaging: HR-CT halo sign → air-crescent; MRI for CNS/sinus.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">4. Histology/BAL/biopsy for EORTC “proven” disease.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">7. Antifungal susceptibility &amp; resistance</h3>
<p class="ml-4 mb-2">• Azole-R A. fumigatus increasing in Europe (environmental TR34/L98H, TR46/Y121F/T289A).</p>
<br/>
<p class="ml-4 mb-2">• Intrinsic AmB-R: A. terreus, A. nidulans.</p>
<p class="ml-4 mb-2">• Always request MICs on invasive isolates.</p>
<h3 class="text-lg font-semibold mt-6 mb-3">8. Management cheat-sheet</h3>
<p class="mb-3">Condition First-line Key alternatives / notes</p>
<p class="mb-3">Invasive aspergillosis Voriconazole Liposomal AmB; isavuconazole</p>
<p class="mb-3">(non-inferior; shortens QT c)</p>
<p class="mb-3">ABPA Oral steroids ±</p>
<p class="mb-3">itraconazole/posaconazole</p>
<p class="mb-3">CPA Long-term oral triazole; monitor</p>
<p class="mb-3">levels</p>
<p class="mb-3">Onychomycosis /</p>
<p class="mb-3">Otomycosis Topical clotrimazole ± oral azole</p>
<p class="mb-3">Surgical Resection of solitary aspergilloma;</p>
<p class="mb-3">debridement of sinus/CNS masses</p>
<p class="mb-3">Supportive: remove colonised lines, taper immunosuppression, give G-CSF if neutropenic.</p>
<h3 class="text-lg font-semibold mt-6 mb-3">9. Prognosis &amp; prevention</h3>
<p class="ml-4 mb-2">• IA mortality: 50-60 % (SOT) → 70-85 % (other immunosuppressed). Early targeted therapy</p>
<p class="mb-3">improves survival .</p>
<p class="ml-4 mb-2">• Primary prophylaxis (e.g. posaconazole in AML/allo-HSCT) cuts incidence but monitor for</p>
<p class="mb-3">resistance.</p>
<p class="ml-4 mb-2">• Environmental control: HEPA filtration, positive-pressure rooms, meticulous dust</p>
<p class="mb-3">containment during building/refurbishment .</p>
<h3 class="text-lg font-semibold mt-6 mb-3">10. High-yield exam pearls</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">1. Columnar uniseriate head + growth to 65 °C = A. fumigatus.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">2. Accessory conidia → think A. terreus (and AmB-R).</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">3. Galactomannan false-positive with piperacillin-tazobactam or Penicillium.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">4. Sterigmatocystin ↔ A. versicolor; ochratoxin ↔ A. terreus; aflatoxin ↔ A. flavus.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">5. Report isolates as “A. fumigatus complex” unless molecular ID performed (≥ 40 cryptic</h3>
<p class="mb-3">species) .</p>
<h3 class="text-lg font-semibold mt-6 mb-3">6. Isavuconazole shortens QTc (contrast other azoles).</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">7. Memorise EORTC/MSG 2008 possible/probable/proven definitions—frequent SAQ.</h3>
<h3 class="text-lg font-semibold mt-6 mb-3">8. Environmental reservoirs (damp concrete, carpets, HVAC) explain hospital outbreak</h3>
<p class="mb-3">questions.</p>
<br/>
<h3 class="text-lg font-semibold mt-6 mb-3">9. Room-temperature growth (~25 °C) onychomycosis isolate? Think A. versicolor.</h3>
<br/>
<br/>
</div>